Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 20:12:34.
doi: 10.1186/1471-2261-12-34.

Local electrogram delay recorded from left ventricular lead at implant predicts response to cardiac resynchronization therapy: retrospective study with 1 year follow up

Affiliations

Local electrogram delay recorded from left ventricular lead at implant predicts response to cardiac resynchronization therapy: retrospective study with 1 year follow up

Rostislav Polasek et al. BMC Cardiovasc Disord. .

Abstract

Background: Considerable proportion of patients does not respond to the cardiac resynchronization therapy (CRT). This study investigated clinical relevance of left ventricular electrode local electrogram delay from the beginning of QRS (QLV). We hypothesized that longer QLV indicating more optimal lead placement in the late activated regions is associated with the higher probability of positive CRT response.

Methods: We conducted a retrospective, single-centre analysis of 161 consecutive patients with heart failure and LBBB or nonspecific intraventricular conduction delay (IVCD) treated with CRT. We routinely intend to implant the LV lead in a region with long QLV. Clinical response to CRT, left ventricular (LV) reverse remodelling (i.e. decrease in LV end-systolic diameter - LVESD ≥10%) and reduction in plasma level of NT-proBNP >30% at 12-month post-implant were the study endpoints. We analyzed association between pre-implant variables and the study endpoints.

Results: Clinical CRT response rate reached 58%, 84% and 92% in the lowest (≤105 ms), middle (106-130 ms) and the highest (>130 ms) QLV tertile (p < 0.0001), respectively. Longer QRS duration (p = 0.002), smaller LVESD and a non-ischemic cardiomyopathy (both p = 0.02) were also univariately associated with positive clinical CRT response. In a multivariate analysis, QLV remained the strongest predictor of clinical CRT response (p < 0.00001), followed by LVESD (p = 0.01) and etiology of LV dysfunction (p = 0.04). Comparable predictive power of QLV for LV reverse remodelling and NT-proBNP response rates was observed.

Conclusion: LV lead position assessed by duration of the QLV interval was found the strongest independent predictor of beneficial clinical response to CRT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Measurement of the QLV. Printout of the electrophysiological recording system at 200 mm/s paper speed showing the interval from the beginning of the native QRS complex to the local electrogram from the LV lead. Labels: Lead II, III, aVR of the surface ECG; RVA-1/2 - right ventricular electrogram; LV-1/2 - LV electrogram; HRA 1/2 - right atrial electrogram.
Figure 2
Figure 2
Relationship of the QLV and CRT effects. The greater QLV at implantation of CRT system correlates with an increase in LVEF, decrease in LVESD, shortening of QRSd, and reduction in NT-proBNP at 12-month follow-up. Pearsons’s correlation coefficients (r) with p-values are provided. Abbreviations as in Table 1.
Figure 3
Figure 3
CRT responder rates in subgroups defined by tertiles of baseline variables. Response rates in percentages when population was categorized by tertiles of the QLV, QLV ratio, QRSd, and LVESD. Grey bars indicate clinical response to CRT and black bars proportion of patients who showed reverse LV remodelling. Abbreviations as in Table 1.

Similar articles

Cited by

References

    1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL. et al.Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845–1853. doi: 10.1056/NEJMoa013168. - DOI - PubMed
    1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG. et al.Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–2150. doi: 10.1056/NEJMoa032423. - DOI - PubMed
    1. Linde C, Abraham WT, Gold MR. St John Sutton M, Ghio S, Daubert C: Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52(23):1834–1843. doi: 10.1016/j.jacc.2008.08.027. - DOI - PubMed
    1. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M. et al.Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344(12):873–880. doi: 10.1056/NEJM200103223441202. - DOI - PubMed
    1. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA. Foster E, Greenberg H, Higgins SL et al: Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329–1338. doi: 10.1056/NEJMoa0906431. - DOI - PubMed

Publication types

MeSH terms